Black Rose Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 20, 2025, 9:44 pm

Competitors of Black Rose Industries Ltd

All Competitor Stocks of Black Rose Industries Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:41 am

Below is a detailed analysis of the quarterly data for Black Rose Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 82.89 Cr.. The value appears to be declining and may need further review. It has decreased from 86.71 Cr. (Dec 2024) to 82.89 Cr., marking a decrease of 3.82 Cr..
• For Expenses, as of Mar 2025, the value is 74.36 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 78.90 Cr. (Dec 2024) to 74.36 Cr., marking a decrease of 4.54 Cr..
• For Operating Profit, as of Mar 2025, the value is 8.53 Cr.. The value appears strong and on an upward trend. It has increased from 7.81 Cr. (Dec 2024) to 8.53 Cr., marking an increase of 0.72 Cr..
• For OPM %, as of Mar 2025, the value is 10.29%. The value appears strong and on an upward trend. It has increased from 9.01% (Dec 2024) to 10.29%, marking an increase of 1.28%.
• For Other Income, as of Mar 2025, the value is 0.43 Cr.. The value appears to be declining and may need further review. It has decreased from 0.96 Cr. (Dec 2024) to 0.43 Cr., marking a decrease of 0.53 Cr..
• For Interest, as of Mar 2025, the value is 0.39 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.30 Cr. (Dec 2024) to 0.39 Cr., marking an increase of 0.09 Cr..
• For Depreciation, as of Mar 2025, the value is 0.78 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.79 Cr. (Dec 2024) to 0.78 Cr., marking a decrease of 0.01 Cr..
• For Profit before tax, as of Mar 2025, the value is 7.79 Cr.. The value appears strong and on an upward trend. It has increased from 7.68 Cr. (Dec 2024) to 7.79 Cr., marking an increase of 0.11 Cr..
• For Tax %, as of Mar 2025, the value is 25.29%. The value appears to be improving (decreasing) as expected. It has decreased from 25.65% (Dec 2024) to 25.29%, marking a decrease of 0.36%.
• For Net Profit, as of Mar 2025, the value is 5.81 Cr.. The value appears strong and on an upward trend. It has increased from 5.70 Cr. (Dec 2024) to 5.81 Cr., marking an increase of 0.11 Cr..
• For EPS in Rs, as of Mar 2025, the value is 1.14. The value appears strong and on an upward trend. It has increased from 1.12 (Dec 2024) to 1.14, marking an increase of 0.02.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:45 am

Growth

Last Updated: September 5, 2025, 2:41 pm

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Black Rose Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 5. It has decreased from 4.16 (Mar 24) to 4.11, marking a decrease of 0.05.
• For Diluted EPS (Rs.), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 5. It has decreased from 4.16 (Mar 24) to 4.11, marking a decrease of 0.05.
• For Cash EPS (Rs.), as of Mar 25, the value is 4.72. This value is within the healthy range. It has decreased from 4.75 (Mar 24) to 4.72, marking a decrease of 0.03.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.97. It has increased from 28.45 (Mar 24) to 29.97, marking an increase of 1.52.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.97. It has increased from 28.45 (Mar 24) to 29.97, marking an increase of 1.52.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 76.71. It has increased from 74.59 (Mar 24) to 76.71, marking an increase of 2.12.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 6.42. This value is within the healthy range. It has increased from 6.40 (Mar 24) to 6.42, marking an increase of 0.02.
• For PBIT / Share (Rs.), as of Mar 25, the value is 5.80. This value is within the healthy range. It has decreased from 5.81 (Mar 24) to 5.80, marking a decrease of 0.01.
• For PBT / Share (Rs.), as of Mar 25, the value is 5.56. This value is within the healthy range. It has decreased from 5.60 (Mar 24) to 5.56, marking a decrease of 0.04.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 4.11. This value is within the healthy range. It has decreased from 4.16 (Mar 24) to 4.11, marking a decrease of 0.05.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.11. This value is within the healthy range. It has decreased from 4.16 (Mar 24) to 4.11, marking a decrease of 0.05.
• For PBDIT Margin (%), as of Mar 25, the value is 8.36. This value is below the healthy minimum of 10. It has decreased from 8.58 (Mar 24) to 8.36, marking a decrease of 0.22.
• For PBIT Margin (%), as of Mar 25, the value is 7.56. This value is below the healthy minimum of 10. It has decreased from 7.79 (Mar 24) to 7.56, marking a decrease of 0.23.
• For PBT Margin (%), as of Mar 25, the value is 7.24. This value is below the healthy minimum of 10. It has decreased from 7.51 (Mar 24) to 7.24, marking a decrease of 0.27.
• For Net Profit Margin (%), as of Mar 25, the value is 5.35. This value is within the healthy range. It has decreased from 5.58 (Mar 24) to 5.35, marking a decrease of 0.23.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.35. This value is below the healthy minimum of 8. It has decreased from 5.58 (Mar 24) to 5.35, marking a decrease of 0.23.
• For Return on Networth / Equity (%), as of Mar 25, the value is 13.70. This value is below the healthy minimum of 15. It has decreased from 14.63 (Mar 24) to 13.70, marking a decrease of 0.93.
• For Return on Capital Employeed (%), as of Mar 25, the value is 18.62. This value is within the healthy range. It has decreased from 19.54 (Mar 24) to 18.62, marking a decrease of 0.92.
• For Return On Assets (%), as of Mar 25, the value is 9.77. This value is within the healthy range. It has decreased from 11.02 (Mar 24) to 9.77, marking a decrease of 1.25.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.07. This value is within the healthy range. It has increased from 0.02 (Mar 24) to 0.07, marking an increase of 0.05.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.92. It has decreased from 2.15 (Mar 24) to 1.92, marking a decrease of 0.23.
• For Current Ratio (X), as of Mar 25, the value is 2.97. This value is within the healthy range. It has decreased from 3.48 (Mar 24) to 2.97, marking a decrease of 0.51.
• For Quick Ratio (X), as of Mar 25, the value is 1.68. This value is within the healthy range. It has decreased from 2.54 (Mar 24) to 1.68, marking a decrease of 0.86.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 4. It has decreased from 1.49 (Mar 24) to 1.01, marking a decrease of 0.48.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 13.21 (Mar 24) to 0.00, marking a decrease of 13.21.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 11.57 (Mar 24) to 0.00, marking a decrease of 11.57.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 86.79 (Mar 24) to 0.00, marking a decrease of 86.79.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 88.43 (Mar 24) to 0.00, marking a decrease of 88.43.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 32.70. This value is within the healthy range. It has increased from 30.57 (Mar 24) to 32.70, marking an increase of 2.13.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 22.17. This value is within the healthy range. It has increased from 20.87 (Mar 24) to 22.17, marking an increase of 1.30.
• For Enterprise Value (Cr.), as of Mar 25, the value is 457.39. It has decreased from 609.04 (Mar 24) to 457.39, marking a decrease of 151.65.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has decreased from 1.60 (Mar 24) to 1.17, marking a decrease of 0.43.
• For EV / EBITDA (X), as of Mar 25, the value is 13.97. This value is within the healthy range. It has decreased from 18.65 (Mar 24) to 13.97, marking a decrease of 4.68.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.64 (Mar 24) to 1.16, marking a decrease of 0.48.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 86.78 (Mar 24) to 0.00, marking a decrease of 86.78.
• For Price / BV (X), as of Mar 25, the value is 2.98. This value is within the healthy range. It has decreased from 4.30 (Mar 24) to 2.98, marking a decrease of 1.32.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.64 (Mar 24) to 1.16, marking a decrease of 0.48.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness